2018 American Transplant Congress Archives - Page 12 of 211

4:42pm-4:54pm: A 3C Approach Drives Epigenetic Fixation of Foxp3 Expression and Stabilizes Treg Cell Lineage and Therapeutic Function

X. Xiao, X. Zhang, J. Li, S. Chen, P. Lan, Y. Dou, W. Chen, X. Li.

Concurrent Session: New Approaches to Target Regulatory T Cells • Room 618/619/620

4:42pm-4:54pm: As Clear as Mud: Volatility of the Five-Tier Quality Assessment of Kidney Transplant Centers in the United States

J. Schold,¹ K. Andreoni,² A. Chandraker,³ R. Gaston,⁴ J. Locke,⁴ A. Mathur,⁵ T. Pruett,⁶ A. Rana,⁷ L. Ratner,⁸ L. Buccini.¹

Concurrent Session: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics - 3 • Room 4C-4

4:42pm-4:54pm: Donor Derived Transmissions in 2016-2017: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

C. Wolfe, S. Tlusty, G. Vece, R. Bag, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, P. Wood, N. Theodoropoulos, M. Michaels.

Concurrent Session: New Frontiers in HIV and Hepatitis • Room 4C-3

4:42pm-4:54pm: Early Results from USHER: A Pilot Trial of Transplanting HCV-Infected Hearts into HCV-Negative Recipients Followed by Anti-Viral Therapy

R. McLean, P. P. Reese, M. Acker, P. Abt, A. Sicilia, N. Hornsby, P. Atluri, K. R. Reddy, E. Blumberg, V. Van Deerlin, D. S. Goldberg.

Concurrent Session: Late Breaking • Room 3AB

4:42pm-4:54pm: Engineering Regulatory T Cells with Interleukin (IL-)2 Nanogel for Improved Alloimmune Suppression

S. Eskandari,¹ M. Bandeira Melo,² J. Assaker,¹ A. Mansouri,¹ S. Cai,¹ B. Al Dulaijan,¹ M. Mohamed,¹ D. Irvine,² J. Azzi.¹

Concurrent Session: Cellular Therapies and to Promote Tolerance • Room 606/607

4:42pm-4:54pm: Follow Up of Patients Treated with the IgG Endopeptidase (IdeS) for Desensitization and HLA Incompatible (HLAi) Kidney Transplantation

S. Jordan,¹ J. Choi,¹ E. Huang,¹ R. Najjar,¹ A. Peng,¹ X. Zhang,¹ S. Louie,¹ M. Haas,² S. Sethi,¹ I. Kim,¹ A. Vo.¹

Concurrent Session: Kidney Immunosuppression: General Considerations - 2 • Room 6A

4:42pm-4:54pm: Hard-To-Place Kidney Offers: System- Level Predictors of Discard

L. Kayler,¹ J. Nie,² K. Noyes,² M. Leeman,³ R. Narvaez.¹

Concurrent Session: Kidney Donor Selection / Management Issues - 2 • Room 6E

4:42pm-4:54pm: Hospital Readmissions Following ABO-Incompatible Live Donor Kidney Transplantation: A National Study

B. Orandi,¹ X. Luo,² S. Bae,² E. King,² J. Garonzik-Wang,² D. Segev.²

Concurrent Session: Quality Assurance Process Improvement • Room 2AB

4:42pm-4:54pm: Improving Prognostication amongst Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: An International, 16-Center Study to Validate and Recalibrate HALTHCC

D. Firl,¹ K. Sasaki,¹ S. Kimura,² W. Dumronggittigule,³ A. Gorgen,⁴ J. Lerut,⁵ M. Rossi,⁶ U. Cillo,⁷ A. Viveiros,⁸ E. Tsochatzis,⁹ G. Otto,¹⁰ G. Ettorre,¹¹ G. Tisone,¹² M. Vivarelli,¹³ S. Agnes,¹⁴ J. Markmann,² T. Ikegami,¹⁵ T. Kaido,¹⁶ G. Sapisochin,⁴ V. Agopian,³ Q. Lai,^5,6 F. Aucejo.¹

Concurrent Session: Liver: Hepatocellular Carcinoma and Other Malignancies • Room 6C

4:42pm-4:54pm: Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

J. Leventhal,¹ J. Galvin,¹ J. Mathew,¹ L. Gallon,¹ D. Stare,¹ K. Kurtenbach,¹ K. Ravindra,³ M. Horwitz,³ J. Miller,¹ M. Abecassis,¹ S. Ildstad.²

Concurrent Session: Tolerance: Clinical Studies • Room 210